Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-26-002036

Options or other derivatives

  • Co-CEO and CFO acquired 49,229 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Martin James Joseph Co-CEO and CFO 2026-01-09 Grant or award · Stock Options (Right to Buy) +49,229 49,229 D
Loading xslF345X05/ownership.xml…